What is the main reason for the decrease in GAAP diluted EPS despite revenue growth?

The decrease in GAAP diluted EPS is primarily due to factors excluded from non-GAAP earnings, such as restructuring and employee severance costs, amortization and other acquisition-related costs, and litigation charges, net. These items, while impacting GAAP results, are not considered reflective of ongoing operational performance.

How did the acquisition of Medtronic's business impact the results?

The acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business was a significant event, completed just before the fiscal year-end. While the full financial impact will be seen in future periods, the company noted it as a strategic move to strengthen its market positioning and add new long-term growth drivers. The filing includes "amortization and other acquisition-related costs" as a non-GAAP exclusion, indicating the ongoing integration and related expenses.

What is Cardinal Health's outlook for fiscal year 2018?

Cardinal Health provided guidance for fiscal year 2018 non-GAAP diluted EPS in the range of $4.85 to $5.10. The company also indicated that while fiscal year 2018 non-GAAP EPS was expected to be down, they are taking discrete actions to improve their trajectory for 2019 and beyond, targeting at least $5.60 for fiscal year 2019.

What is the difference between GAAP and non-GAAP EPS, and why does Cardinal Health report both?

GAAP (Generally Accepted Accounting Principles) EPS represents the earnings per share calculated according to standard accounting rules. Non-GAAP EPS excludes certain items that management believes do not reflect the core, ongoing operations of the business, such as restructuring costs, amortization of acquired intangibles, and litigation charges. Cardinal Health provides non-GAAP EPS as a supplemental metric to offer additional perspective on performance and to allow for better year-over-year and peer comparisons, as these excluded items can be unpredictable and volatile.

CAH 8-K: Earnings & Results & Regulation FD

Summary

Cardinal Health reported its fourth-quarter and full-year fiscal 2017 results, demonstrating revenue growth driven by its Pharmaceutical and Medical segments. While total revenue increased, GAAP diluted earnings per share (EPS) saw a decrease, attributed to various charges and investments. However, on a non-GAAP basis, which excludes certain one-time or non-recurring items, EPS showed an increase, signaling operational strength. The company highlighted significant strategic actions taken during the fiscal year to strengthen market position and diversify its portfolio, including a substantial acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business. Despite a dynamic healthcare landscape and challenges encountered, Cardinal Health successfully grew its scale and added new growth drivers. The company also provided its fiscal year 2018 guidance, projecting a range for non-GAAP diluted EPS and indicating a target for fiscal year 2019, suggesting a focus on long-term trajectory improvement.

Key Highlights

1Fourth-quarter revenue increased 5% to $33 billion, and full-year revenue grew 7% to a record $130 billion.
2GAAP diluted EPS decreased 16% to $0.86 for the quarter and 7% to $4.03 for the full year.
3Non-GAAP diluted EPS increased 15% to $1.31 for the quarter and 3% to $5.40 for the full year, excluding significant charges.
4Pharmaceutical segment revenue rose 5% in Q4 and 7% for the full year, while segment profit declined due to generic pricing and IT investments.
5Medical segment revenue increased 6% in Q4 and 9% for the full year, with segment profit showing strong growth.
6Completed a major acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business for $6.1 billion.
7Provided fiscal year 2018 guidance for non-GAAP diluted EPS between $4.85 and $5.10, and targeted at least $5.60 for fiscal year 2019.

CARDINAL HEALTH INC 8-K Report, Financial Results (Aug 2, 2017)

Summary

Key Highlights

Frequently Asked Questions